155 related articles for article (PubMed ID: 24363084)
1. Genetic variants in NAMPT predict bladder cancer risk and prognosis in individuals from southwest Chinese Han group.
Zhang K; Zhou B; Zhang P; Zhang Z; Chen P; Pu Y; Song Y; Zhang L
Tumour Biol; 2014 May; 35(5):4031-40. PubMed ID: 24363084
[TBL] [Abstract][Full Text] [Related]
2. Association of Nicotinamide Phosphoribosyltransferase (NAMPT) Gene Polymorphisms and of Serum NAMPT Levels with Dilated Cardiomyopathy in a Chinese Population.
Dou Q; Peng Y; Zhou B; Zhang K; Lin J; Dai X; Zhang L; Rao L
Int J Mol Sci; 2015 Sep; 16(9):22299-318. PubMed ID: 26389889
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms of NAMPT related with susceptibility to esophageal squamous cell carcinoma.
Zhang C; Yan D; Wang S; Xu C; Du W; Ning T; Liu C; Zhang M; Hou R; Chen Z
BMC Gastroenterol; 2015 Apr; 15():49. PubMed ID: 25896907
[TBL] [Abstract][Full Text] [Related]
4. Impact of genetic variants of ABCB1, APOB, CAV1, and NAMPT on susceptibility to pancreatic ductal adenocarcinoma in Chinese patients.
Li B; Zhang C; Wang J; Zhang M; Liu C; Chen Z
Mol Genet Genomic Med; 2020 Jun; 8(6):e1226. PubMed ID: 32243098
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of serum nicotinamide phosphoribosyltransferase in patients with bladder cancer.
Zhang K; Zhou B; Zhang P; Zhang Z; Chen P; Pu Y; Song Y; Zhang L
Croat Med J; 2014 Oct; 55(5):507-13. PubMed ID: 25358883
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of PDCD6 polymorphisms and the susceptibility to bladder cancer.
Zhou B; Zhang P; Tang T; Zhang K; Wang Y; Song Y; Liao H; Zhang L
Tumour Biol; 2014 Aug; 35(8):7547-54. PubMed ID: 24792888
[TBL] [Abstract][Full Text] [Related]
7. Accelerated cardiovascular risk after viral clearance in hepatitis C patients with the NAMPT-rs61330082 TT genotype: An 8-year prospective cohort study.
Chang ML; Lin YS; Chang MY; Hsu CL; Chien RN; Fann CS
Virulence; 2021 Dec; 12(1):270-280. PubMed ID: 33446046
[TBL] [Abstract][Full Text] [Related]
8. The role of oncostatin M receptor gene polymorphisms in bladder cancer.
Deng S; He SY; Zhao P; Zhang P
World J Surg Oncol; 2019 Feb; 17(1):30. PubMed ID: 30755233
[TBL] [Abstract][Full Text] [Related]
9. Correlation of IL-31 gene polymorphisms with susceptibility and clinical recurrence of bladder cancer.
Li Q; Tang T; Zhang P; Liu C; Pu Y; Zhang Y; Song H; Wang Y; Song Y; Su M; Zhou B; Zhang L
Fam Cancer; 2018 Oct; 17(4):577-585. PubMed ID: 29116431
[TBL] [Abstract][Full Text] [Related]
10. Associations between Interleukin-32 Gene Polymorphisms rs12934561 and rs28372698 and Susceptibilities to Bladder Cancer and the Prognosis in Chinese Han Population.
Yang J; Jian Z; Shen P; Bai Y; Tang Y; Wang J
Dis Markers; 2020; 2020():8860445. PubMed ID: 33204366
[TBL] [Abstract][Full Text] [Related]
11. Lack of association of NAMPT rs9770242 and rs59744560 polymorphisms with disease susceptibility and cardiovascular risk in patients with rheumatoid arthritis.
García-Bermúdez M; González-Juanatey C; Rodríguez-Rodríguez L; Miranda-Filloy JA; Perez-Esteban S; Vazquez-Rodriguez TR; Castañeda S; Balsa A; Fernández-Gutierrez B; Llorca J; González-Alvaro I; Martín J; González-Gay MA
Clin Exp Rheumatol; 2011; 29(4):681-8. PubMed ID: 21906432
[TBL] [Abstract][Full Text] [Related]
12. TGFB1 and TGFBR1 polymorphic variants in relationship to bladder cancer risk and prognosis.
Castillejo A; Rothman N; Murta-Nascimento C; Malats N; García-Closas M; Gómez-Martínez A; Lloreta J; Tardón A; Serra C; García-Closas R; Chanock S; Silverman DT; Dosemeci M; Kogevinas M; Carrato A; Soto JL; Real FX
Int J Cancer; 2009 Feb; 124(3):608-13. PubMed ID: 19004027
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms and plasma levels of IL-27: impact on genetic susceptibility and clinical outcome of bladder cancer.
Zhou B; Zhang P; Tang T; Liao H; Zhang K; Pu Y; Chen P; Song Y; Zhang L
BMC Cancer; 2015 May; 15():433. PubMed ID: 26014498
[TBL] [Abstract][Full Text] [Related]
14. Glutathione S-transferase M1 and T1 polymorphisms: susceptibility and outcomes in muscle invasive bladder cancer patients.
Kang HW; Song PH; Ha YS; Kim WT; Kim YJ; Yun SJ; Lee SC; Choi YH; Moon SK; Kim WJ
Eur J Cancer; 2013 Sep; 49(14):3010-9. PubMed ID: 23810248
[TBL] [Abstract][Full Text] [Related]
15. Association of single nucleotide polymorphisms in promoter of matrix metalloproteinase-2, 8 genes with bladder cancer risk in Northern India.
Srivastava P; Kapoor R; Mittal RD
Urol Oncol; 2013 Feb; 31(2):247-54. PubMed ID: 21784671
[TBL] [Abstract][Full Text] [Related]
16. The association between matrix metalloproteinase-7 genetic variant and bladder cancer risk in a Chinese Han population.
Mao F; Niu XB; Gu S; Ji L; Wei BJ; Wang HB
Clin Exp Med; 2019 Nov; 19(4):565-570. PubMed ID: 31576476
[TBL] [Abstract][Full Text] [Related]
17. Do DNA repair genes OGG1, XRCC3 and XRCC7 have an impact on susceptibility to bladder cancer in the North Indian population?
Gangwar R; Ahirwar D; Mandhani A; Mittal RD
Mutat Res; 2009; 680(1-2):56-63. PubMed ID: 19815090
[TBL] [Abstract][Full Text] [Related]
18. Caspase 9 and caspase 8 gene polymorphisms and susceptibility to bladder cancer in north Indian population.
Gangwar R; Mandhani A; Mittal RD
Ann Surg Oncol; 2009 Jul; 16(7):2028-34. PubMed ID: 19412632
[TBL] [Abstract][Full Text] [Related]
19. Association between lncRNA H19 (rs217727, rs2735971 and rs3024270) polymorphisms and the risk of bladder cancer in Chinese population.
Li Z; Niu Y
Minerva Urol Nefrol; 2019 Apr; 71(2):161-167. PubMed ID: 29595036
[TBL] [Abstract][Full Text] [Related]
20. GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study.
Matic M; Pekmezovic T; Djukic T; Mimic-Oka J; Dragicevic D; Krivic B; Suvakov S; Savic-Radojevic A; Pljesa-Ercegovac M; Tulic C; Coric V; Simic T
Urol Oncol; 2013 Oct; 31(7):1184-92. PubMed ID: 24075358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
